ADM unpacks postbiotics and strain-specific microbiome clinical trials
Expanding research on the gut microbiome and its connections to other health areas is driving product development in the nutrition industry. ADM says advances in women’s health metabolites, the gut-brain axis, and strain-specific clinical research are helping companies develop more targeted, evidence-based solutions. Nutrition Insight discusses microbiome breakthroughs and clinical research with Dr. Malwina Naghibi, head of Clinical Development in ADM’s R&D Medical Team.This Technical Paper is brought to you by Lallemand Bio-Ingredients.
At IFT FIRST 2026, Beneo’s senior nutrition communications manager, Denisse Colindres, outlined ingredient strategies tailored to different stages of the GLP-1 weight management journey. She explained the importance of fiber diversity within the “fibermaxxing” trend, rather than simply increasing fiber intake. Colindres highlighted how viscous, fermentable, soluble, and insoluble fibers can support satiety, metabolic health, digestion, and mood.
Settings
- Play Interval
- Slide Duration
- Thumbnail Bar Position
Latest headlines

Smart sugar control Aug 2026

Advanced immune supportAug 2026
Multimedia
At IFT FIRST 2026, Beneo’s senior nutrition communications manager, Denisse Colindres, outlined ingredient strategies tailored to different stages of the GLP-1 weight management journey. She explained the importance of fiber diversity within the “fibermaxxing” trend, rather than simply...
Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Texture challenges in high protein bars: Understanding the benefits of casein
Lactalis Ingredients





























